Latest Insider Transactions at Brightcove Inc (BCOV)
This section provides a real-time view of insider transactions for Brightcove Inc (BCOV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BRIGHTCOVE INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BRIGHTCOVE INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
16,806
+0.25%
|
$50,418
$3.0 P/Share
|
|
Nov 01
2024
|
David Plotkin Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,410
-2.94%
|
$20,820
$2.07 P/Share
|
|
Oct 22
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,307
+0.02%
|
$2,614
$2.08 P/Share
|
|
Oct 21
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,500
+0.05%
|
$7,000
$2.08 P/Share
|
|
Oct 18
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,562
+0.1%
|
$13,124
$2.07 P/Share
|
|
Sep 26
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.3%
|
$40,000
$2.07 P/Share
|
|
Sep 19
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,901
+0.04%
|
$5,802
$2.0 P/Share
|
|
Sep 18
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,096
+0.03%
|
$4,192
$2.0 P/Share
|
|
Sep 12
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,003
+0.08%
|
$10,006
$2.0 P/Share
|
|
Sep 10
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,230
+0.08%
|
$10,460
$2.04 P/Share
|
|
Sep 06
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,600
+0.18%
|
$23,200
$2.04 P/Share
|
|
Aug 23
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,485
+0.07%
|
$8,970
$2.08 P/Share
|
|
Aug 22
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.08%
|
$10,000
$2.07 P/Share
|
|
Aug 14
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,806
+0.21%
|
$27,612
$2.02 P/Share
|
|
Aug 12
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,000
+0.3%
|
$20,000
$1.98 P/Share
|
|
Aug 09
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.46%
|
$60,000
$2.01 P/Share
|
|
Jun 17
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,081
+0.05%
|
$3,081
$1.97 P/Share
|
|
Jun 14
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.08%
|
$5,000
$1.98 P/Share
|
|
Jun 10
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.08%
|
$10,000
$2.02 P/Share
|
|
Jun 06
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,700
+0.09%
|
$11,400
$2.02 P/Share
|
|
May 13
2024
|
John Brandon Wagner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
275,000
+50.0%
|
-
|
|
May 08
2024
|
Tsedal Neeley Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+26.51%
|
-
|
|
May 08
2024
|
Thomas E Wheeler Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+21.79%
|
-
|
|
May 08
2024
|
Gary E Haroian Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+22.84%
|
-
|
|
May 08
2024
|
Diane Hessan Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+22.26%
|
-
|
|
May 08
2024
|
Scott Kurnit Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+14.76%
|
-
|
|
May 08
2024
|
Kristin E. Frank Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+24.77%
|
-
|
|
Apr 16
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
46,831
+0.71%
|
$46,831
$1.69 P/Share
|
|
Apr 15
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,000
+0.15%
|
$10,000
$1.68 P/Share
|
|
Apr 12
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,351
+0.1%
|
$6,351
$1.7 P/Share
|
|
Apr 11
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,824
+0.06%
|
$3,824
$1.78 P/Share
|
|
Apr 10
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.08%
|
$5,000
$1.8 P/Share
|
|
Apr 02
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,190
+0.08%
|
$5,190
$1.85 P/Share
|
|
Apr 02
2024
|
Marc De Bevoise Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
875,000
+31.01%
|
-
|
|
Apr 02
2024
|
David Plotkin Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
175,000
+33.08%
|
-
|
|
Mar 28
2024
|
Marc De Bevoise Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
51,050
-4.55%
|
$51,050
$1.94 P/Share
|
|
Mar 20
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,000
+0.46%
|
$30,000
$1.88 P/Share
|
|
Mar 11
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
33,300
+0.26%
|
$33,300
$1.88 P/Share
|
|
Mar 10
2024
|
Marc De Bevoise Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
53,094
-4.51%
|
$53,094
$1.95 P/Share
|
|
Mar 10
2024
|
Robert Noreck Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,797
-4.35%
|
$9,797
$1.95 P/Share
|
|
Mar 10
2024
|
David Plotkin Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,036
-4.8%
|
$9,036
$1.95 P/Share
|
|
Feb 27
2024
|
Marc De Bevoise Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+2.08%
|
$50,000
$2.03 P/Share
|
|
Feb 26
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,400
+0.07%
|
$4,400
$1.85 P/Share
|
|
Feb 23
2024
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
37,347
+0.29%
|
$37,347
$1.85 P/Share
|
|
Dec 10
2023
|
David Plotkin Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,257
-1.19%
|
$4,514
$2.4 P/Share
|
|
Dec 10
2023
|
Robert Noreck Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,504
-1.1%
|
$5,008
$2.4 P/Share
|
|
Nov 10
2023
|
Marc De Bevoise Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+1.71%
|
$40,000
$2.48 P/Share
|
|
Nov 06
2023
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,000
+0.09%
|
$12,000
$2.48 P/Share
|
|
Nov 02
2023
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,139
+0.18%
|
$22,278
$2.55 P/Share
|
|
Nov 01
2023
|
Robert Noreck Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,876
-4.96%
|
$23,752
$2.84 P/Share
|